Constructs Sequence pUAST-Syx13
Forward: 5'-CG CTC GAG ATGTCCAAGGCCTTGAAC-3' Reverse: 5'-GC TCT AGA TTAACTGTTCAGTTTGGC-3' pUAST-HA-Syx13
Forward:5'-CGCTCGAGATGTACCCATATGATGTTCCTGATT ATGCT ATGTCCAAGGCCTTGAAC-3' Reverse: 5'-GC TCT AGA TTAACTGTTCAGTTTGGC-3'
pUAST -c-MycdVti1
Forward:5'-CGCTCGAGATGGAACAAAAACTAATTTCTG AAGAAGATCTA ATGTCGCTTCTGGAGCAATAC-3' Reverse:5'-GC TCT AGA CTACGACGAGGCGGTGCT-3' HEK293T and HeLa cells were cultured in Dulbecco's modified Eagle's medium (Sigma) supplemented with 10% fetal calf serum (Sigma). Cells were maintained in a humidified incubator at 37°C and 5% CO 2 . All siRNAs for gene silencing were from Qiagen (Table S3 ). Full-length human STX13 was amplified and subcloned into the modified pCMV-c-Myc, EGFP-C1 (Clonetech) and TagBFP-C (Evrogen) vectors (Table   S4 ). The dual-color LC3 vector (mCherry-GFP-LC3) was kindly provided by Dr. Ana Maria Cuervo. Autophagic flux was quantified with Image-Pro-Plus software; the same threshold was set for all pictures. RFP-LC3 and EGFP-Atg5 were from Addgene.
Constructs Sequences

EGFP-STX13
Chemicals and rapamycin were from Sigma. Cells were treated with 1 M rapamycin for 24 hours. Full-length Vti1a was synthesized and subcloned into pCMV-HA (GenScript). 
Cell Viability Assay
Cell viability in terms of mitochondrial dehydrogenase activity was measured and analyzed by the MTT assay. HEK293 Cells were seeded in 96-well plates 1 day prior to transfection, and then transfected with various plasmids or siRNAs fort 48h-72hs. The
MTT assay was performed with CellTiter 96 non-Radioactive Cell Proliferation Assay kit (Promega). The medium was removed and replaced with 100 µl of fresh medium with MTT (Promega) for 4 hours. The formazon crystals produced were further dissolved in 100 µl of solubilization solution. Absorbance at 570 nm was measured with a UV plate reader. All experiments were done in triplicate.
